Individualizing Cancer Therapies Using “Anatomolecular” Imaging
June 25th, 2008
A number of oncology-specific PET indications for ^sup 18^F-FDG have been approved or partially approved by CMS. These include applications in solitary pulmonary nodules (SPNs), non-small cell lung cancer, colon cancer, Hodgkin’s and non-Hodgkin’s lymphomas (NHL), melanoma, head and neck cancer, esophageal cancer, thyroid cancer, and breast cancer.